NGNE · Neurogene Inc. · Documents

$27.58 +0.91 (+3.41%)

Russell 2000 member Rebalance outlook locked

Market Cap

$533.70M

20.01M

Volume · Nov 4 208.56K Avg daily vol (3M) 292.95K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022

Mar 1

Current report 8-K Events of Feb 25

Financial results, Director or officer change, or executive pay

Mar 1

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Net loss $60.69M Diluted EPS -$1.10

Feb 15

Current report 8-K Events of Feb 14

Director or officer change, or executive pay

Jan 10

Current report 8-K

Regulation FD disclosure, Other events

2021

Nov 19

Current report 8-K Events of Nov 17

Director or officer change, or executive pay

Nov 16

Current report 8-K

Other events

Nov 4

Current report 8-K

Financial results

Nov 4

Current report 8-K

Entered into a material agreement

Nov 4

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Net loss $15.45M Diluted EPS -$0.28

Sep 29

Current report 8-K

Regulation FD disclosure, Other events

Aug 5

Current report 8-K

Financial results, Regulation FD disclosure

Aug 5

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Net loss $15.13M Diluted EPS -$0.27

Jun 2

Current report 8-K

Regulation FD disclosure

May 14

Current report 8-K Events of May 13

Shareholder vote results

May 12

Current report 8-K Events of May 11

Financial results, Regulation FD disclosure

May 12

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Net loss $14.95M Diluted EPS -$0.27

Mar 31

Proxy statement DEF 14A Meeting May 13, 2021

Proxy statement

Mar 31

Proxy statement DEFA14A

Proxy statement

Mar 25

Current report 8-K

Financial results

Mar 25

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Net loss $33.28M

Jan 11

Current report 8-K

Regulation FD disclosure

2020

Dec 11

Registration statement S-3

Registration statement

Dec 1

Current report 8-K Events of Nov 25

Entered into a material agreement

Nov 9

Current report 8-K

Financial results

Nov 9

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Net loss $2.25M

Sep 10

Current report 8-K Events of Sep 6

Director or officer change, or executive pay

Aug 12

Current report 8-K

Financial results

Aug 12

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Net loss $9.75M

Aug 3

Current report 8-K

Regulation FD disclosure

Jul 2

Current report 8-K Events of Jul 1

Entered into a material agreement, Other events

Jun 1

Current report 8-K Events of May 29

Director or officer change, or executive pay

May 6

Current report 8-K Events of May 5

Shareholder vote results

May 6

Current report 8-K

Financial results

May 6

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Net loss $8.64M

Apr 17

Current report 8-K Events of Apr 15

Director or officer change, or executive pay

Apr 16

Proxy statement DEFA14A

Proxy statement

Apr 13

Current report 8-K Events of Apr 9

Charter or bylaw amendment, or fiscal year change

Mar 24

Proxy statement DEF 14A Meeting May 5, 2020

Proxy statement

Mar 24

Proxy statement DEFA14A

Proxy statement

Mar 20

Current report 8-K

Change of auditor

Mar 12

Current report 8-K

Financial results

Mar 12

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Net loss $69.44M

Mar 10

Current report 8-K

Shareholder director nominations, Other events

Feb 25

Current report 8-K

Director or officer change, or executive pay

Jan 13

Current report 8-K

Regulation FD disclosure

Showing 101–145 of 145 documents

Key facts CIK 1404644 CUSIP 64135M105 13F (30d) 23 filings 23 filers Visit website Investor relations